Stock ALPMY ASTELLAS PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Astellas Pharma Inc. OTC Markets

Equities

ALPMY

US04623U1025

Delayed OTC Markets
Other stock markets
 12:15:22 2024-06-06 EDT 		5-day change 1st Jan Change
10.16 USD -0.68% Intraday chart for Astellas Pharma Inc. +4.75% -14.71%
06-03 US FDA Acknowledges Astellas Pharma's Resubmission of Biologics License Application for Zolbetuximab MT
05-31 U.S. Food and Drug Administration Acknowledges Astellas Pharma Inc.? Resubmission of Biologics License Application for Zolbetuximab and Sets New Action Date CI

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4503 Stock
  4. ALPMY Stock
  5. News Astellas Pharma Inc.
  6. MarketScreener Strategies